July 2018

Contents

Editorial

• 11 July 2018: vol 19 no 12: DTG and preconception – special report

Special reports

• Fit for purpose: Antiretroviral treatment optimisation July 2018

• Fit for purpose 2018 – PDF

• HIV pipeline 2018: full version

• Dolutegravir preconception signal: time is up for shoddy surveillance

Conference reports

• What to watch: HIV cure-related research at AIDS 2018

• AIDS 2018: Programme online and late-breaker highlights announced three weeks before the conference

Antiretrovirals

• Bictegravir/FTC/TAF (Biktarvy) approved in Europe

Women's health

• Dolutegravir: need to consider all pros and cons before switching in pregnancy

Pregnancy

• Why U=U does not apply to breastfeeding

PDFs

• 11 July 2018: vol 19 no 12